Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - lacosamidum - compresse rivestite con film - lacosamidum 100.00 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum silicificatum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, e 171, talcum, e 172 (flavum), pro compresso obducto. - antiepileptikum - synthetika

Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - lacosamidum - compresse rivestite con film - lacosamidum 150.00 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum silicificatum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus) macrogolum 3350, e 171, talcum, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - antiepileptikum - synthetika

Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - lacosamidum - compresse rivestite con film - lacosamidum 200.00 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum silicificatum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171 macrogolum 3350, talcum, e 132, pro compresso obducto. - antiepileptikum - synthetika

Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - lacosamidum - sirup - lacosamidum 10 mg, e 218 2.27 mg, glycerolum (85 per centum), sorbitolum 187 mg, macrogolum 4000, carmellosum natricum, acidum citricum monohydricum, natrii citras dihydricus, sucralosum, aromatica (erdbeer) cum propylenglycolum, maltolum, natrii chloridum, aqua purificata, ad solutionem pro 1 ml corresp. natrium max. 1.6 mg. - antiepileptikum - synthetika

Europos Sąjunga - italų - EMA (European Medicines Agency)

ucb pharma sa - brivaracetam - epilessia - antiepilettici, - briviact è indicato come terapia aggiuntiva nel trattamento delle crisi ad esordio parziale con o senza generalizzazione secondaria in pazienti adulti e adolescenti dai 16 anni di età con epilessia.

Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - phenytoinum - compresse - phenytoinum 100 mg, lactosum monohydricum 53.2 mg, maydis amylum, gelatina, silica colloidalis anhydrica, carmellosum natricum corresp. natrium 0.07 mg, magnesii stearas pro compresso. - antiepilepticum - synthetika

Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - phenytoinum - compresse - phenytoinum 100 mg, cellulosum microcristallinum, maydis amylum, carboxymethylamylum natricum a corresp. natrium 0.38 mg, silicii dioxidum praecipitatum, gelatina, silica colloidalis anhydrica, magnesii stearas, talcum, aqua purificata, pro compresso. - antiepilepticum - synthetika

Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

ucb-pharma sa - lacosamidum - soluzione versare perfusione - lacosamidum 10 mg, natrii chloridum, acidum hydrochloridum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 3.0 mg. - aed - synthetika

Europos Sąjunga - italų - EMA (European Medicines Agency)

angelini pharma s.p.a - cenobamate - epilessia - antiepilettici, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.

Šveicarija - italų - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - lacosamidum - soluzione per infusione - lacosamidum 10.0 mg, natrii chloridum, acidum hydrochloridum q.s. ad ph, natrii hydroxidum q.s. ad ph, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 2.99 mg. - antiepileptikum - synthetika